Guidance for industry : acceptance of foreign clinical studies.
| Corporate Authors: | Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), Center for Devices and Radiological Health (U.S.) |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
[Rockville, Md.] :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research : Center for Devices and Radiological Health,
[2001]
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/LPS115319 |
Similar Items
Guidance for industry : E 10 choice of control group and related issues in clinical trials.
Published: (2001)
Published: (2001)
Guidance for industry : information program on clinical trials for serious or life-threatening diseases and conditions.
Published: (2002)
Published: (2002)
Guidance for industry : E9 statistical principles for clinical trials.
Published: (1998)
Published: (1998)
Guidance for industry : submitting and reviewing complete responses to clinical holds.
Published: (2000)
Published: (2000)
Guidance for industry : computerized systems used in clinical trials.
Published: (1999)
Published: (1999)
Guidance for industry : collection of race and ethnicity data in clinical trials.
Published: (2005)
Published: (2005)
Guidance for industry : gene therapy clinical trials, observing subjects for delayed adverse events.
Published: (2006)
Published: (2006)
Guidance for clinical trial sponsors : establishment and operation of clinical trial data monitoring committees.
Published: (2006)
Published: (2006)
Guidance for industry : independent consultants for biotechnology clinical trial protocols.
Published: (2004)
Published: (2004)
Guidance for industry : M4S, the CTD, safety.
Published: (2001)
Published: (2001)
Guidance for industry : M4S, the CTD, safety appendices.
Published: (2001)
Published: (2001)
Guidance for industry : E6 good clinical practice, consolidated guidance.
Published: (1996)
Published: (1996)
Guidance for industry : postmarketing studies and clinical trials, implementation of section 505(o) of the Federal Food, Drug, and Cosmetic Act.
Published: (2009)
Published: (2009)
Guidance for industry : IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer.
Published: (2004)
Published: (2004)
Guidance for industry : E 10 choice of control group and related issues in clinical trials.
Published: (2001)
Published: (2001)
Guidance for industry : M4Q, the CTD, quality.
Published: (2001)
Published: (2001)
Reviewer guidance : conducting a clinical safety review of a new product application and preparing a report on the review.
Published: (2005)
Published: (2005)
Guidance for industry : M4E, the CTD, efficacy.
Published: (2001)
Published: (2001)
Guidance for industry : computerized systems used in clinical investigations.
Published: (2007)
Published: (2007)
Guidance for industry : toxicity grading schedule for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials.
Published: (2007)
Published: (2007)
Guidance for industry : E2B(M), data elements for transmission of individual case study reports, questions and answers.
Published: (2005)
Published: (2005)
Guidance for industry : E2BM data elements for transmission of individual case safety reports.
Published: (2002)
Published: (2002)
Guideline for the monitoring of clinical investigations.
Published: (1988)
Published: (1988)
Structure and content of clinical study reports.
Published: (1996)
Published: (1996)
Guidance for industry : M4, the CTD, general questions and answers.
Published: (2004)
Published: (2004)
Guidance for industry : M4, the CTD, efficacy questions and answers.
Published: (2004)
Published: (2004)
Information sheet : guidance for institutional review boards and clinical investigators (acceptance of foreign clinical studies).
Published: (1998)
Published: (1998)
Guidance for clinical investigators, institutional review boards, and sponsors : process for handling referrals to FDA under 21 CFR 50.54 : additional safeguards for children in clinical investigations.
Published: (2006)
Published: (2006)
Clinical trials roadmap for physician practices /
by: Morgan, Christie L.
Published: (2004)
by: Morgan, Christie L.
Published: (2004)
Guidance for clinical investigators, sponsors, and IRBs : adverse event reporting to IRBs : improving human subject protection.
Published: (2009)
Published: (2009)
Guidance for industry : supplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors.
Published: (2006)
Published: (2006)
Guidance for industry : submitting marketing applications according to the ICH-CTD format, general considerations.
Published: (2001)
Published: (2001)
The Clinical research process in the pharmaceutical industry /
Published: (1984)
Published: (1984)
Guidance for industry : granularity document : annex to M4, organization of the CTD.
Published: (2005)
Published: (2005)
Implementing a national cancer clinical trials system for the 21st century : workshop summary /
Published: (2011)
Published: (2011)
Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals.
Published: (2008)
Published: (2008)
A first-order characterization of clinical trials /
by: Hopwood, Marsha
Published: (1980)
by: Hopwood, Marsha
Published: (1980)
Guidance for industry : Prescription Drug Marketing Act, donation of prescription drug samples to free clinics.
Published: (2006)
Published: (2006)
PLoS clinical trials.
Published: (2006)
Published: (2006)
An insider's guide to clinical trials /
by: Meinert, Curtis L.
Published: (2011)
by: Meinert, Curtis L.
Published: (2011)